Cathie Wood Is Buying the CoreWeave Dip and Selling Palantir Omor Ibne Ehsan Fri, November 13, 2026 at 9:37 AM EST 5 min read CRWV -8.76% PLTR -0.78% NVDA -2.32% ARKK -1.54% TWST -3.28% Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
ARK bought $16 million of CoreWeave on a 7% dip while trimming $10 million of Palantir, which trades at 244 times earnings.
NVIDIA's CEO exit and a rival neocloud's soft guidance triggered CoreWeave's slide, raising doubts about the $2 billion NVIDIA partnership.
CoreWeave's $132 billion backlog cannot offset heavy debt, steep interest costs, and customer concentration, with its top customer generating 67% of revenue.
The biggest 401k decisions tend to get made once and never revisited: when to roll it over, what to hold inside it, and when to start taking money out. That is exactly what the report: 401k & IRA Tips and Answers was created to address, and it is free today. Read more here. (Sponsor)
ARK Invest bought 283,022 shares of CoreWeave (NASDAQ:CRWV) on Thursday, November 12, 2026. The purchase was worth about $16 million, and it came on a day the stock fell 6.86% to $56.60. From the same two funds, ARK sold 58,339 Palantir (NASDAQ:PLTR) shares worth about $10 million. Palantir barely moved, dropping 0.48% to $171.58.
ARK has not said why it made the trades, but Cathie Wood's firm added to a debt-funded AI infrastructure builder after a decline and reduced an AI software winner that trades at a premium price.
Both trades ran through the main ARK Innovation ETF (BATS:ARKK) and a sister internet fund. The November 12 holdings file for ARKK shows about 2,431,528 CoreWeave shares, or 2.37% of the fund, and about 948,590 Palantir shares, or 2.63%.
On the same day, ARK also bought about $8.9 million of Twist Bioscience (NASDAQ:TWST) and sold pieces of several other holdings, so the Palantir sale was one part of a wider rotation. Palantir is still one of ARKK's larger positions, so the sale was a trim rather than an exit.
For many Americans, funding a 401(k) only leads to more retirement questions. Should you roll your 401k into an IRA, and when? What's the tax impact if the rollover check gets made out to the wrong name? When do required withdrawals begin, and how much do you have to take?
Fisher Investments put the answers in one place. 401k & IRA Tips and Answers is free, and it covers rollovers, contribution limits, required withdrawals, and what actually belongs inside the account once the balance gets serious. Read More Here ›
CoreWeave reported third-quarter results on November 10 and closed that day at $48.73. On November 11, it rose 24.71% to $60.77. On November 12, it fell as low as $50.17 before closing at $56.60. That close is still above the pre-earnings level, but the stock was down 27.26% for the month through November 12.
Two reasons were reported for the slide. One was soft guidance from a rival, Neocloud (an AI-focused cloud provider). The other was doubt about support from NVIDIA (NASDAQ:NVDA) after Jensen Huang resigned as its CEO. NVIDIA invested $2 billion in CoreWeave stock in January 2026. CoreWeave's CEO said he saw "no reason" for the partnership to change, but he said it on November 11, before Huang left.
CoreWeave is valued at about $25.97 billion. Its third-quarter revenue grew 168% to $3.66 billion, and its backlog stands at $132.5 billion. It also plans $37 billion to $39 billion of capital spending and lost $709 million in the quarter, which included $846 million of net interest expense.
The backlog helps lock in future revenue. It does nothing to address the cost of financing all that spending or how much CoreWeave depends on a few buyers. Its top customer generated about 67% of 2025 revenue.
Palantir is valued at about $395.78 billion. Its debt-to-equity ratio is 0.03, its net margin is 36.3%, and third-quarter revenue rose 95.9% to $2.313 billion. The cost of that quality is a price of about 244 times earnings.
On November 12, Barclays cut its CoreWeave price target to $85 from $105, and Argus cut its target to $100 from $150. Both targets are still above the share price. Even so, analysts cut them right after a quarter that beat estimates, which suggests they now see more financing risk.
For investors near retirement, CoreWeave carries significant risk. The company carries heavy debt, and it has an at-the-market program (new shares sold gradually into the market) of up to 35 million shares that could dilute existing holders. Its key supplier also now has new leadership.
ARK itself holds CoreWeave at 2.37% of ARKK. That is small enough for a high-risk fund to handle if the investment goes wrong.
Palantir has a stronger financial profile, even though ARK reduced it. The company expects $4.8 billion to $5.0 billion of adjusted free cash flow for 2026. Its 17.77% drop through November 12 has also cut the price investors pay for that growth.
Keep an eye on NVIDIA's earnings report on November 17. If CoreWeave ends below $48.73 after that report, it will have given back its entire post-earnings rally, and that would point to deeper concern about its financing. If it closes back above $60.77, the November 12 drop was probably just noise.
(sponsor) 401(k)s are powerful retirement tools. But even savvy savers can make mistakes that quietly cost you money for decades. Choosing the wrong fund, ignoring small fees nobody adds up, rollover steps done in the wrong order, the list goes on.
These sort of mistakes is exactly what 401k & IRA Tips and Answers was created to help prevent. It is a free guide from Fisher Investments on rollovers, contributions, required withdrawals and the mistakes that do the most damage to a retirement account. Learn More Here ›
Contact editorial@247wallst.com for any questions or corrections.
